Surgery Partners, Inc.

Total Valuation

Surgery Partners, Inc. carries a market capitalization of 2.13B, placing it among publicly traded companies globally. Its enterprise value stands at 7.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Surgery Partners, Inc. currently has 130.80M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.46, and the price-to-book ratio stands at -1.79.

Enterprise Valuation

On an enterprise value basis, Surgery Partners, Inc. trades at an EV/EBITDA multiple of 11.13 and an EV/FCF ratio of 12.13. The EV/Sales ratio of 2.14 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.39 provides insight into valuation relative to core operating earnings.

Financial Position

Surgery Partners, Inc. maintains a current ratio of 1.86, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 115.70, indicating elevated leverage, while an interest coverage ratio of 2.30 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Surgery Partners, Inc. has paid 16.80M in income taxes, reflecting an effective tax rate of 14.75.

Stock Price Statistics

Surgery Partners, Inc.'s stock has declined approximately -26.11061% over the past 52 weeks. The 50-day moving average sits at 14.89, while the 200-day moving average is 15.65.

Income Statement

Over the trailing twelve months, Surgery Partners, Inc. generated 3.34B in revenue and converted that into -76.10M in net income, yielding earnings per share of 0.76. EBITDA reached 643.50M, while operating income came in at 465.30M.

Balance Sheet

Surgery Partners, Inc. holds 182.30M in cash and equivalents against 4.03B in total debt, resulting in a net debt position of 3.53B. Total book value stands at -849.80M, with working capital of 500.80M providing operational flexibility.

Cash Flow

Surgery Partners, Inc. produced 280.00M in operating cash flow over the past twelve months. After subtracting -72.00M in capital expenditures, free cash flow totaled 208.00M - equivalent to 1.63 per share.

Margins

Surgery Partners, Inc. operates with a gross margin of 22.83, reflecting its pricing power and cost economics. The operating margin of 13.92 and net profit margin of -2.28 provide insight into operational efficiency.

Dividends & Yields

Scores

Surgery Partners, Inc. posts an Altman Z-Score of 1.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.